Pacific Biosciences of California Stock Forecast for 2023 - 2025 - 2030
Updated on 02/05/2023
Pacific Biosciences of California Stock Forecast and Price Target
Year-long price target forecasts from prominent analysts have recently been released for Pacific Biosciences of California, with an average price target of $16.50. This potential gain of 42.49 percent from the previous closing price in February, 2023 is calculated on a high forecast of $27.00 and a low estimate of $6.00. If you're thinking of investing in PACB stock, it might be good to look at its rivals too.
42.49% Upside
Pacific Biosciences of California Fair Value Forecast for 2023 - 2025 - 2030
Pacific Biosciences of California's Price has grown In the last two years, rising from $0.00 to $0.00 – a growth of 100.00%. In the next year, analysts believe that Fair Value will reach $11.45 – an increase of 100.00%. For the next nine years, experts predict that Pacific Biosciences of California's Fair Value will grow at a rate of 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|
| TMO Stock Forecast | Thermo Fisher Scientific Inc | Outperform |
10
|
$587.76 | $618.99 | 5.49% |
| ILMN Stock Forecast | Illumina Inc | Outperform |
16
|
$214.26 | $254.08 | 16.45% |
| QGEN Stock Forecast | QIAGEN N.V. | Outperform |
15
|
$49.54 | $0.00 | 11.02% |
| TXG Stock Forecast | 10x Genomics | Outperform |
6
|
$47.84 | $0.00 | 109.03% |
| 300676 Stock Forecast | BGI Genomics | Outperform |
17
|
¥56.82 | ¥0.00 | 867.09% |
Pacific Biosciences of California Revenue Forecast for 2023 - 2025 - 2030
Pacific Biosciences of California's Revenue has grown In the last two years, rising from $90.89M to $130.51M – a growth of 43.59%. According to the 0 analysts polled, in the next year, Pacific Biosciences of California's Revenue will fall by 21.30%, reaching $102.72M. By 2030, professionals believe that Pacific Biosciences of California's Revenue will have decreased by 18.66%, falling to $106.15M.
Pacific Biosciences of California Free Cash Flow Forecast for 2023 - 2025 - 2030
In the last two years, Pacific Biosciences of California's Free Cash Flow has grown, moving from $-81.15M to $-112.22M – an increase of 38.29%. In the following year, 0 experts forecast Pacific Biosciences of California's Free Cash Flow will decrease by 102.23%, to $2.51M. Looking ahead to nine years, experts forecast that Free Cash Flow will grow by 9358.70%.
Pacific Biosciences of California Net Income Forecast for 2023 - 2025 - 2030
In the last two years, Pacific Biosciences of California's Net Income has grown by 115.40%, rising from $-84.13M to $-181.22M. According to 0 prominent analysts, Pacific Biosciences of California's Net Income will fall by 51.24% in the next year, reaching $-88.36M. By 2030, professionals believe that Pacific Biosciences of California's Net Income will decrease by 29.42%, reaching $-127.91M – a concerning trend for the company.
Pacific Biosciences of California EBITDA Forecast for 2023 - 2025 - 2030
In the last two years, Pacific Biosciences of California's EBITDA has seen an increase, rising from $-93.28M to $-170.89M. This represents a growth of 83.20%. According to 0 major analysts, Pacific Biosciences of California's EBITDA will fall by 30.31% in the next year, reaching $-119.09M. Professionals believe that By 2030, Pacific Biosciences of California's EBITDA will fall to $-128.36M– a 24.89% decrease from its current value.
Pacific Biosciences of California EBIT Forecast for 2023 - 2025 - 2030
Pacific Biosciences of California's EBIT has seen growth In the last two years, going from $-100.55M to $-178.16M – a gain of 77.19% In the next year, 0 analysts estimate that Pacific Biosciences of California's EBIT will decrease by 29.11%, reaching $-126.29M. According to professional forecasts, in 2030, Pacific Biosciences of California's EBIT will decrease by 24.11%, reaching $-135.21M.
Pacific Biosciences of California EPS Price Prediction Forecast for 2023 - 2025 - 2030
Pacific Biosciences of California's EPS has grown In the last two years, rising from $-0.58 to $-0.93 – a growth of 60.34%. According to the 0 analysts polled, in the next year, Pacific Biosciences of California's EPS will fall by 24.37%, reaching $-0.70. By 2030, professionals believe that Pacific Biosciences of California's EPS will have decreased by 20.69%, falling to $-0.74.